Efalizumab (Anti-Integrin aL / ITGAL / CD11a)
Efalizumab (Anti-Integrin aL / ITGAL / CD11a) is a humanized IgG1 monoclonal antibody directed against CD11a, the alpha subunit of human leukocyte-function-associated antigen type 1 (LFA-1), with immunosuppressant activity. MW: 145.5 kD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2421 |
Sku # | A2421-1mg |
Pricing | 1mg, $370.00 |